Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond

by Javad Garousi, Anna Orlova, Fredrik Y. Frejd, Vladimir Tolmachev
Published 2020-06-01

Cellular effects of HER3-specific affibody molecules.

by Lovisa Göstring, Magdalena Malm, Ingmarie Höidén-Guthenberg, Fredrik Y Frejd, Stefan Ståhl, John Löfblom, Lars Gedda
Published 2012-01-01

Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer

by Ali Alhuseinalkhudhur, Mark Lubberink, Henrik Lindman, Vladimir Tolmachev, Fredrik Y. Frejd, Joachim Feldwisch, Irina Velikyan, Jens Sörensen
Published 2020-03-01

Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody^® Molecules ¹⁷⁷Lu-ABY-271 and ¹⁷⁷Lu-ABY-027: Impact of DOTA Position on ABD...

by Yongsheng Liu, Anzhelika Vorobyeva, Tianqi Xu, Anna Orlova, Annika Loftenius, Theresa Bengtsson, Per Jonasson, Vladimir Tolmachev, Fredrik Y. Frejd
Published 2021-06-01

Preclinical Evaluation of ^99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake

by Maryam Oroujeni, Sara S. Rinne, Anzhelika Vorobyeva, Annika Loftenius, Joachim Feldwisch, Per Jonasson, Vladimir Chernov, Anna Orlova, Fredrik Y. Frejd, Vladimir Tolmachev
Published 2021-03-01

Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

by Magdalena Malm, Nina Kronqvist, Hanna Lindberg, Lindvi Gudmundsdotter, Tarek Bass, Fredrik Y. Frejd, Ingmarie Höidén-Guthenberg, Zohreh Varasteh, Anna Orlova, Vladimir Tolmachev, Stefan Ståhl, John Löfblom
Published 2013-01-01

Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification.

by Magdalena Malm, Nina Kronqvist, Hanna Lindberg, Lindvi Gudmundsdotter, Tarek Bass, Fredrik Y. Frejd, Ingmarie Höidén-Guthenberg, Zohreh Varasteh, Anna Orlova, Vladimir Tolmachev, Stefan Ståhl, John Löfblom
Published 2013-01-01

Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification.

by Magdalena Malm, Nina Kronqvist, Hanna Lindberg, Lindvi Gudmundsdotter, Tarek Bass, Fredrik Y Frejd, Ingmarie Höidén-Guthenberg, Zohreh Varasteh, Anna Orlova, Vladimir Tolmachev, Stefan Ståhl, John Löfblom
Published 2013-01-01

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model

by Allal Boutajangout, Allal Boutajangout, Allal Boutajangout, Allal Boutajangout, Hanna Lindberg, Abdulaziz Awwad, Arun Paul, Arun Paul, Rabaa Baitalmal, Rabaa Baitalmal, Ismail Almokyad, Ismail Almokyad, Ingmarie Höidén-Guthenberg, Elin Gunneriusson, Fredrik Y. Frejd, Torleif Härd, John Löfblom, Stefan Ståhl, Thomas Wisniewski, Thomas Wisniewski, Thomas Wisniewski, Thomas Wisniewski
Published 2019-03-01